Brookfield Asset Management Inc. Amgen Inc Transaction History

Brookfield Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$214.27 - $253.37 $275,336 - $325,580	-1,285 Reduced 53.21%	1,130 $250,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $275,336 - $325,580	-1,285 Reduced 53.21%	1,130 $250,000
Q1 2023 Sep 25, 2023	BUY	$225.79 - $275.2 $290,140 - $353,632	1,285 Added 113.72%	2,415 $583,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $545,282 - $664,608	2,415 New	2,415 $583,000
Q2 2022 Nov 16, 2022	BUY	$230.71 - $256.74 $5.13 Million - $5.71 Million	22,242 New	22,242 $5.41 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $5.67 Million - $6.31 Million	-24,572 Reduced 52.49%	22,242 $5.41 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $8.71 Million - $9.63 Million	39,703 Added 558.33%	46,814 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.41 Million - $1.62 Million	7,111 New	7,111 $1.6 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.